Authors:
Fowler, JS
Ding, YS
Logan, J
MacGregor, RR
Shea, C
Garza, V
Gimi, R
Volkow, ND
Wang, GJ
Schlyer, D
Ferrieri, R
Gatley, SJ
Alexoff, D
Carter, P
King, P
Pappas, N
Arnett, CD
Citation: Js. Fowler et al., Species differences in [C-11]clorgyline binding in brain, NUCL MED BI, 28(7), 2001, pp. 779-785
Citation: Js. Fowler et al., [(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy, NUCL MED BI, 28(5), 2001, pp. 561-572
Authors:
Rice, OV
Gatley, SJ
Shen, J
Huemmer, CL
Rogoz, R
DeJesus, OT
Volkow, ND
Gifford, AN
Citation: Ov. Rice et al., Effects of endogenous neurotransmitters on the in vivo binding of dopamineand 5-HT radiotracers in mice, NEUROPSYCH, 25(5), 2001, pp. 679-689
Citation: J. Logan et al., A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone, J NEURAL TR, 108(3), 2001, pp. 279-286
Authors:
Volkow, ND
Chang, L
Wang, GJ
Fowler, JS
Franceschi, D
Sedler, M
Gatley, SJ
Miller, E
Hitzemann, R
Ding, YS
Logan, J
Citation: Nd. Volkow et al., Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence, J NEUROSC, 21(23), 2001, pp. 9414-9418
Authors:
Volkow, ND
Wang, GJ
Fowler, JS
Logan, J
Gerasimov, M
Maynard, L
Ding, YS
Gatley, SJ
Gifford, A
Franceschi, D
Citation: Nd. Volkow et al., Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain, J NEUROSC, 21(2), 2001, pp. NIL_1-NIL_5
Authors:
Fowler, JS
Volkow, ND
Logan, J
Franceschi, D
Wang, GJ
MacGregor, R
Shea, C
Garza, V
Pappas, N
Carter, P
Netusil, N
Bridge, P
Liederman, D
Elkashef, A
Rotrosen, J
Hitzemann, R
Citation: Js. Fowler et al., Evidence that L-deprenyl treatment for one week does not inhibit MAO A or the dopamine transporter in the human brain, LIFE SCI, 68(24), 2001, pp. 2759-2768
Citation: Nd. Volkow et al., Imaging brain cholinergic activity with positron emission tomography: Its role in the evaluation of cholinergic treatments in Alzheimer's dementia, BIOL PSYCHI, 49(3), 2001, pp. 211-220
Authors:
Volkow, ND
Chang, L
Wang, GJ
Fowler, JS
Leonido-Yee, M
Franceschi, D
Sedler, MJ
Gatley, SJ
Hitzemann, R
Ding, YS
Logan, J
Wong, C
Miller, EN
Citation: Nd. Volkow et al., Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers, AM J PSYCHI, 158(3), 2001, pp. 377-382
Authors:
Volkow, ND
Chang, L
Wang, GJ
Fowler, JS
Franceschi, D
Sedler, MJ
Gatley, SJ
Hitzemann, R
Ding, YS
Wong, C
Logan, J
Citation: Nd. Volkow et al., Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers, AM J PSYCHI, 158(3), 2001, pp. 383-389
Authors:
Volkow, ND
Chang, L
Wang, GJ
Fowler, JS
Ding, YS
Sedler, M
Logan, J
Franceschi, D
Gatley, J
Hitzemann, R
Gifford, A
Wong, C
Pappas, N
Citation: Nd. Volkow et al., Low level of brain dopamine D-2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex, AM J PSYCHI, 158(12), 2001, pp. 2015-2021
Citation: Nd. Volkow et Js. Fowler, Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex, CEREB CORT, 10(3), 2000, pp. 318-325
Citation: J. Logan et al., Reproducibility of repeated measures of deuterium substituted [C-11]L-deprenyl ([C-11]L-deprenyl-D2) binding in the human brain, NUCL MED BI, 27(1), 2000, pp. 43-49
Authors:
Gerasimov, MR
Franceschi, M
Volkow, ND
Rice, O
Schiffer, WK
Dewey, SL
Citation: Mr. Gerasimov et al., Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor, SYNAPSE, 38(4), 2000, pp. 432-437
Authors:
Cosenza, M
Gifford, AN
Gatley, SJ
Pyatt, B
Liu, Q
Makriyannis, A
Volkow, ND
Citation: M. Cosenza et al., Locomotor activity and occupancy of brain cannabinoid CB1 receptors by theantagonist/inverse agonist AM281, SYNAPSE, 38(4), 2000, pp. 477-482
Authors:
Gatley, SJ
Gifford, AN
Carroll, FI
Volkow, ND
Citation: Sj. Gatley et al., Sensitivity of binding of high-affinity dopamine receptor radioligands to increased synaptic dopamine, SYNAPSE, 38(4), 2000, pp. 483-488